Vir Biotechnology Inc (VIR)
9.59
+0.22
(+2.35%)
USD |
NASDAQ |
Nov 05, 11:47
Vir Biotechnology Total Liabilities (Quarterly): 257.63M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 257.63M |
| June 30, 2024 | 235.88M |
| March 31, 2024 | 246.61M |
| December 31, 2023 | 328.82M |
| September 30, 2023 | 369.81M |
| June 30, 2023 | 433.67M |
| March 31, 2023 | 695.14M |
| December 31, 2022 | 724.12M |
| September 30, 2022 | 546.12M |
| June 30, 2022 | 666.98M |
| March 31, 2022 | 886.12M |
| December 31, 2021 | 522.42M |
| Date | Value |
|---|---|
| September 30, 2021 | 333.94M |
| June 30, 2021 | 320.26M |
| March 31, 2021 | 484.63M |
| December 31, 2020 | 201.91M |
| September 30, 2020 | 130.90M |
| June 30, 2020 | 108.46M |
| March 31, 2020 | 96.78M |
| December 31, 2019 | 88.13M |
| September 30, 2019 | 703.44M |
| June 30, 2019 | 55.40M |
| December 31, 2018 | 370.77M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
88.13M
Minimum
Dec 2019
886.12M
Maximum
Mar 2022
383.92M
Average
331.38M
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 128.22B |
| Biomarin Pharmaceutical Inc | 1.438B |
| Arbutus Biopharma Corp | 37.59M |
| GlycoMimetics Inc | 4.356M |
| FibroGen Inc | 483.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.498B |
| Shareholders Equity (Quarterly) | 1.241B |
| Current Ratio | 8.938 |